Objetivo. Estimar la incidencia de infarto al miocardio (IM) en población mexicana de nivel socioeconómico bajo. Material y métodos. Estudio longitudinal de 1696 hombres y mujeres de 35 a 64 años de edad y sin IM basal. IM fue definido por electrocardiograma o certificado de defunción. El riesgo de IM se evaluó con regresión logística múltiple. Resultados. Durante el seguimiento (mediana de 6.2 años) 62 participantes desarrollaron IM o murieron por éste. La incidencia de IM ajustada por edad en hombres y mujeres fue de 6.6 y 4.8 por 1 000 años-persona, respectivamente. El riesgo de IM estuvo asociado con diabetes (RM=2.42, p= 0.003), presión arterial sistólica (RM= 1.28 por cada 10 mm Hg, p= 0.013) y colesterol total (RM= 1.36 por cada 50 mg/ dL, p=0.038). Conclusiones. La incidencia de IM en esta población, puede ser debida a la alta prevalencia de diabetes y colesterol elevado. Es necesario tomar medidas preventivas para disminuir estos factores de riesgo. 
T he incidence of coronary heart disease (CHD), particularly myocardial infarction (MI), has increased in most regions of the world over the past decades. This trend is associated with a mounting prevalence and incidence of classic cardiovascular risk factors such as obesity, diabetes, dyslipidemia, hypertension, and smoking, among others. [1] [2] [3] The combination of those risk factors affects modern westernized societies by increasing the likelihood of death from cardiovascular diseases. 4, 5 Little is known about the incidence of MI in the general population, but available data strongly support the concept of a rising epidemic. Prevalence of associated cardiovascular risk factors is very high; mortality figures show an increase of significant proportion, and information on the incidence of MI in population-based studies confirm the high prevalence rates. 1, 4 Therefore, estimations of the incidence of MI and its predictors are of strategic value to design clearly indicated interventions proved useful in some populations. This study aimed at evaluating the incidence of MI in a low-income Mexican population and at quantifying its association with some classic cardiovascular risk factors.
Material and Methods

Study design
The Mexico City Diabetes Study is a prospective, population-based research designed to describe the prevalence and incidence of diabetes and cardiovascular risk factors in a low-income urban population in Mexico City. Our methods have been described previously. 6 In summary, the study began in 1989-1990 defining a low-income sector of Mexico City. The study site encompassed six census tracts with a total population of 15 532 inhabitants. All 35 to 64 year-old men and non-pregnant women (at time of interview) who permanently resided in the site were considered eligible. We identified 3 505 subjects (22.6%); a home interview was obtained from 3 319 (response rate, 94.7%). At the end of the interview, each participant was invited to undergo a physical and laboratory examination. We performed 2 282 exams (response rate, 68.8%). Two follow-ups were carried out every 3.5 years. After finishing the examination, all participants received a letter with the results of the evaluation. Participants with a specific diagnosis were referred to the physician or institution where they usually receive medical care. A total of 1 696 subjects without MI at baseline, corroborated by electrocardiogram (ECG), were included in the present study, after exclusion of 86 subjects with previous MI detected by ECG, 492 without ECG at baseline, and eight without follow-up examination. When comparing included and excluded subjects without MI at baseline, we found no differences with regard to sex, BMI, diabetes, serum cholesterol, HDL-cholesterol and triglycerides; however, we observed significant age differences (46.9 vs. 48.2 years, respectively), hypertension (18.0 vs. 24.1%, respectively) and current smoking (28.5 vs. 16.6%, respectively).
Current smoking was defined as having at least one cigarette per day in the last year. Body mass index (BMI) was calculated as weight/height 2 in kg/m 2 . Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg, a diastolic blood pressure (DBP) ≥90 mmHg, or treatment with anti-hypertensive drugs. 7 A glucose tolerance test was carried out after an overnight fast and 2-hours after a 75 g oral carbohydrate. Diabetes was diagnosed as fasting glucose ≥126 mg/dl, 2-hour glucose ≥200 mg/dl or treatment with hypoglycemic medication. 8 Serum cholesterol, high-density level (HDL) cholesterol, triglycerides and fasting insulin levels were also determined. Non-HDL cholesterol (serum cholesterol-HDL cholesterol) was calculated as well.
In subjects without MI at baseline, incident MI was identified through follow-up by ECG or death certificate. An ECG was performed on each participant at every examination. We obtained standard interpretations of each ECG at a reading center that used the Minnesota Code for interpretation (Wake Forest University, EPICARE Center). Codes for possible or probable MI: Q-QS pattern with 1.1-1.2.7, Q-QS and T wave pattern 1.2.8-1.3, and wave T pattern with 5.1-5.3. 9 We used the death certificate during the time of the study as a criterion when MI was included among the direct or adjacent causes of death in subjects without previous MI on ECG. The cause of death was classified in accordance with the International Classification of Diseases 10 th Rev. (ICD 10 th , codes 410.0-410.9).
10
After the second follow-up examination, all subjects were contacted by phone or visited at their home to confirm if they were still alive. Information on dead subjects was available from family members (wife, husband, daughter, son, sister or brother) who provided either a death certificate or a verbal autopsy.
Laboratory determinations were performed in the research laboratory of the Division of Clinical Epidemiology at the Department of Medicine of the University of Texas Health Science Center at San Antonio, USA. 
Data analysis
Baseline measurements of the cardiovascular risk factors were used. Incidence was calculated as the number of persons who developed MI divided by person-years of follow-up and expressed per 1 000 person-years at risk. The period of risk began at the first research examination in subjects free of MI at baseline and ended when MI was detected at a research examination, at the last examination in subjects who did not develop MI, or at death, whichever came first. Age-standardized rates of MI and their 95% confidence interval (95% CI) were estimated using the direct method, taking the 1995 total Mexican population as a standard population. Serum cholesterol (<200, 200-240 and ≥240 mg/dL) and triglycerides (<150 and ≥150 mg/dL) levels were classified according to standard categories, whereas non-HDL cholesterol (median 154.5 mg/dL) and fasting insulin (median 12.5 UI) levels were divided into lower than their median and equal or higher than their median. Incidence rate ratios (IRRs) assuming Poisson distribution were calculated as well as their 95% CI. To estimate the association between some classic cardiovascular risk factors and MI, multiple logistic regression analysis was applied. The goodnessof-fit of the model using the Hosmer-Lemeshow test, residuals, and influence statistics were estimated. All analyses were conducted using STATA/SE 9.0 (Stata statistical software: Release 9. College Station. Texas: Stata Corporation, 2005).
Results
Of 1 696 subjects included in this study, 700 (41.3%) were men and 996 (58.7%) were women. Mean age at the beginning was alike for both men and women. Prevalence of diabetes (men 12.3%, women 13.3%) and hypertension (men 15.1%, women 15.9%) was also similar for men and women. Current smoking among men was more than twice the proportion among women (42.6 and 18.4%, respectively). The mean non-HDL cholesterol was higher for men, whereas the mean of fasting insulin was higher for women (Table I) . Considering diabetes, hypertension, high total serum cholesterol (≥200 mg/ dL), and smoking as major cardiovascular risk factors, 66.1% of the subjects showed at least one of those, the prevalence being higher for men (74.1%) than for women (60.4%). As for diabetes and hypertension, 9.6% of the subjects (162/1 696) had only the former, 12.3% (208/1696) had only the latter and 3.3% (56/1696) had both. Regarding serum cholesterol, 37.5% of the subjects (627/1 671) had high levels, and of those, 30.1% (189/627) also had diabetes and/or hypertension.
During a median follow-up of 6.2 years (range 0.4-10.9 years), 62 subjects (30 men and 32 women) experien- ced an MI; 37 were confirmed by ECG (60%) and 25 by death certificate (40%). At the end of the follow-up, mean age of subjects with MI was 58.4 years (SD 9.3 years), and that of subjects without MI was 53.6 years (SD 8.1 years) (p< 0.001). Mean age at death was lower for men than for women (56.4 versus 60.2 years). Age-specific incidence increased with age for both sexes. Age-adjusted incidence rate for MI was slightly higher, but not significant, for men (6.6 per 1 000 person-years) than for women (4.8 per 1 000 person-years), with a men-to-women ratio of 1.4:1 (Table II) . The age and sex-adjusted IRRs of MI for diabetes, BMI, and serum cholesterol were significant. The incidence of MI in subjects with diabetes was 3.12 (95% CI 1.83-5.33) times higher than that for subjects without MI. When analyzing separately diabetic and non-diabetic subjects, we found that the IRR of MI was higher for men than for women in both cases, but these differences were not significant (data not shown). Obese subjects had 2.20 (95% CI 1.00-4.85) times higher risk of suffering a MI than non-obese subjects. For serum cholesterol, a gradient on the IRR was observed, but the IRR was significant only when comparing serum cholesterol ≥240 mg/dL vs. serum cholesterol <200 mg/ dL (IRR 2.78, 95% CI 1.52-5.09) (Table III) . To estimate the relation between some cardiovascular risk factors and the incidence of MI, a multiple logistic regression model was employed. Subjects with diabetes had a 2.42 (95% CI 1.35-4.35) times higher risk of developing MI than subjects without diabetes. A 10 mmHg increase in SBP was associated with 1.28 times (95% CI 1.05-1.53) the risk of MI. Other variables significantly associated with MI were age (OR=1.41 per 5 years, 95% CI 1.17-1.70) and serum cholesterol (OR=1.36 per 50 mg/dL, 95% CI 1.02-1.81). The association between sex, DBP, BMI and anti-hypertensive medications was not significant (Table IV) .
Discussion
The data shown in this study are the first of its kind obtained from a Mexican population. The incidence rate of MI accords with the high prevalence of classic cardiovascular risk factors among this population, such as diabetes, hypertension, and dyslipidemia. [12] [13] [14] Also, the 2000 National Health Survey in Mexico 15 confirmed the high prevalence, at a national level, of the cardiovascular risk factors mentioned previously. Compared to Mexican-Americans, a high frequency of fatal and nonfatal MI among Mexicans has been explained, in part, by access to health care. 16 As for mortality, cardiovascular diseases are the main general cause of death in Mexico, and coronary heart disease (CHD) is the most common condition among those (first cause of death for men and second cause of death for women). 17 In the present study, 66.1% of the participants had at least one of the four major cardiovascular risk factors: diabetes, hypertension, hypercholesterolemia or smoking, regardless of obesity. However, only diabetes, SBP, and serum cholesterol were associated with the incidence of MI. With respect to the frequency of some cardiovascular risk factors from the NHANES III, a higher prevalence of elevated blood pressure (62.5%), obesity (55.0%), triglycerides (42.8%), HDL cholesterol (39.5%) and fasting glucose (27.2%) was reported. Nevertheless, only diabetes and HDL cholesterol were associated with the prevalence of CHD in that population. 18 The associated risk factors identified in the incident cases in this study coincide with the traditional cardiovascular profile model. [19] [20] [21] [22] We should underscore the high lethality of cardiovascular diseases, specifically MI, conferred by several classic cardiovascular risk factors among both men and women. 1, 23, 24 It should also be noted that, similar to other populations, 1, 3, 23 women Table II numBer of cases and age-and sex-specific myocardial infarction incidence rates for a low-income population in mexico city, 1989-1997 had a lower cardiovascular risk profile than men, which was associated with a lower incidence of MI in younger women. 3, 12 However, we observed that the incidence for older women was basically the same as that for men (14.5 vs. 15.4 per 1000 person-years, respectively), which may be accounted for by the rising prevalence in recent years of some risk factors among women.
In this study, diabetes but not insulin levels was significantly associated with the incidence of MI after adjustment for other cardiovascular risk factors. As for other populations, men had a greater risk of developing MI than women, whereas for subjects with diabetes the risk was similar for both men and women, thus the difference between sexes may be due, in part, Same missing values as those in Table I to the diabetes effect. 25 It has been documented as well that the risk of CHD mortality due to diabetes in absence of cardiovascular disease is similar to that associated with a history of MI without diabetes. 26, 27 Additionally, we found differences in the proportion of fatal and non-fatal MI among subjects with (16/22) and without type 2 diabetes (9/40), and fatal cases were overrepresented in the former, thus the worst cardiovascular profile in subjects with diabetes is strongly related to mortality from MI.
An increased risk of developing MI was significantly associated with serum cholesterol levels ≥240 mg/dL. A graded positive relation between serum cholesterol and CHD has been shown in several populations, whereas a protective effect of HDL cholesterol has been reported, particularly among women. 28 No significant association was found between MI and BMI after adjusting for other cardiovascular risk factors. Obesity in other populations clearly increased the risk of cardiovascular disease regardless of other risk factors; however, obesity is a better predictor of cardiovascular disease for women and for younger people.
26,29 SBP but not hypertension in this population was associated with MI, possibly because of recent hypertension diagnosis in some cases. Both hypertension and its control have been shown to be related to CHD mortality in subjects with and without diabetes. 26, 30 We have attempted to maintain rigorous methodology and diagnostic criteria during the study. An expert panel interpreted the ECGs using internationally accepted procedures. Our fieldwork enabled us to maintain reasonable follow-up of our population. However, because of the number of subjects without baseline ECG, we may be underestimating the true incidence of MI. In addition, because MI cases defined by ECG did not include clinical information, this could introduce a misclassification bias; the assumption was that we reduced the bias because all subjects were free of MI at baseline. To ascertain vital status, all subjects were contacted to confirm whether they were still alive. If the participant had died, we obtained the death certificate from a family member or from the institution (which provided the certificate). We concluded that the incidence of MI was similar for both men and women after adjustment for age. While MI is often lethal, the most commonly associated major cardiovascular risk factors are all amenable to viable, previously proven, successful public health interventions that should diminish its high impact on the population. Current general and specific recommendations must be exhaustively implemented to substantially decrease classic cardiovascular risk factors for specific risk groups.
